Home
|
About
|
Quick Start
|
FAQ
Beta Version 0.1
DHARA is an online index of articles on Ayurveda published in research journals worldwide.
Users Online:
849
Unfiltered
Classified Search
Enter Keyword Below :
Advanced
Journal of Drug Research in Ayurvedic Sciences
2019
July- September
;
4
(3)
:113 -118
Evaluation of Antihyperglycemic and Hypoglycemic Activities of Shadguna Makaradhwaja and Guduchi Ghana in Swiss Albino Mice
Vaibhav A Charde (1)
,
Vaibhav A Charde (1)
,
Kishor P Patel (2)
,
Kishor P Patel (2)
,
Harmeet Kaur (3)
,
Harmeet Kaur (3)
,
Chandrashekhar Jagtap (1)
,
Chandrashekhar Jagtap (1)
,
Mukesh Nariya (4)
,
Mukesh Nariya (4)
,
Biswajyoti Patgiri (5)
,
Biswajyoti Patgiri (5)
,
Soma N Murthy (6)
,
Soma N Murthy (6)
,
Pradeepkumar Prajapat (7)
,
Pradeepkumar Prajapat (7)
1. Regional Ayurved Research Institute, Jhansi, Uttar Pradesh, India 2. Central Ayurveda Research Institute for Cardiovascular Diseases, New Delhi, India 3. Department of Rasashastra and Bhaishajya Kalpana, Desh Bhagat Ayurvedic College and Hospital, Mandi Gobidgarh, Punjab, India 4. Department of Pharmacology, Institute for Postgraduate Teaching and Research in Ayurveda, Jamnagar, Gujarat, India 5. 6 Department of Rasashastra and Bhaishajya Kalpana, Institute for Postgraduate Teaching and Research in Ayurveda, Jamnagar, Gujarat, India 6. Regional Ayurved Research Institute, Jhansi, Uttar Pradesh, India 7. Department of Rasashastra and Bhaishajya Kalpana, All India Institute of Ayurveda, New Delhi, India
Abstract
Background: Diabetes mellitus (DM) is a group of metabolic disorders which share the common phenotype of hyperglycemia that occurs due to defects in insulin secretion, insulin action, or sometimes both. Herbomineral formulations can be the alternative for contemporary synthetic oral hypoglycemic agents due to their potency, suitability, and negligible side effects. Makaradhwaja is one of those potent antidiabetic drugs used in Ayurved. Objectives: To evaluate the hypoglycemic and antihyperglycemic activity of Shadguna Makaradhwaja (SM) formulations prepared by Swarna Varkha (SMV) and from residue Apakwa Talastha Swarna powder (SMR) with Guduchi Ghana (GG) in Swiss albino mice. Materials and methods: Oral glucose tolerance test and 18 hours fasted mice model were used. Shadguna Makaradhwaja with GG (5.85:94.15 ratios) was administered with honey at a dose of 65 mg/kg. Glibenclamide (GB; 0.65 mg/kg) was used as the standard drug. Results: In hypoglycemic study, SMV showed 18.2, 27.83, 34.88, and 47.41%, while SMR showed 4.85, 20.52, 29.70, and 44.3% reduction in blood sugar level (BSL) at 1, 2, 3, and 5 hours, respectively. In antihyperglycemic study, SMV showed 81.73, 49.23, 14.8, and 0% and SMR showed 56.38, 42.23, 1.16, and 21.58% reduction in BSL at 30, 60, 90, and 120 minutes, respectively. Both results were statistically significant when compared to the control group. Conclusion: Test drugs showed significant hypoglycemic and antihyperglycemic effects as compared to the control group. SMV showed more hypoglycemic effect, while SMR showed better antihyperglycemic effect. Keywords: Ayurved, Diabetes mellitus, Herbomineral, Makaradhwaja, Rasashastra
DHARA ID:
D060779
Link To Full Paper
Copyright
|
Disclaimer
|
Feedback
|
Updates
|
Contact
Developed and maintained by AVP Research Foundation (Formerly AVT Institute for Advanced Research), 136/137, Trichy Road, Ramanathapuram, Coimbatore - 641045, Tamil Nadu, India
Funded by Central Council for Research in Ayurvedic Sciences, Dept. of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi